IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.89 USD
-0.08 (-4.06%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $1.88 -0.01 (-0.53%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
Brokerage Reports
IRIDEX Corporation [IRIX]
Reports for Purchase
Showing records 1 - 20 ( 110 total )
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
3Q23 Recap - G6 Noise Continues; Strategic Review Ongoing
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
1Q23 Recap - Compelling Valuation and Declining Losses
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
3Q22 Recap - Growth, Runway, and a Significant Discount
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
Company: IRIDEX Corporation
Industry: Lasers Systems and Components
2Q22 Recap - Choppy Quarter, But Priced for Worse
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S